He received his M.D. from Fudan University Shanghai Medical College (formerly Shanghai Medical University), China in 1989, and his Ph.D. (Doctor of Medical Science) from Kyoto University, Japan in 1997. Dr. Zhang has published over 25 articles in peer-reviewed scientific journals and book chapters. His research focuses on understanding the role of receptor tyrosine kinases (RTKs) signaling, particularly MET and EGFR in cancer and other diseases, and exploring therapeutic strategies by targeting these RTK pathways for disease intervention.